Leo I. Gordon

Leo I. Gordon

Hematology | Oncology

675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 191 publications

Regulation of Lipid Oxidation and Ferroptosis By a Tunable Axis of Vitamin E, High-Density Lipoprotein, and Scavenger Receptor Class B Type 1.

Regulation of Lipid Oxidation and Ferroptosis By a Tunable Axis of Vitamin E, High-Density Lipoprotein, and Scavenger Receptor Class B Type 1.

Journal: The Journal of biological chemistry

Published: March 14, 2026

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 11, 2026

Sequencing T-cell therapy for relapsed or refractory large B-cell lymphoma.

Sequencing T-cell therapy for relapsed or refractory large B-cell lymphoma.

Journal: The Lancet. Haematology

Published: November 19, 2025

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

Journal: Blood

Published: November 05, 2025

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 09, 2025

Measuring group‑ and individual‑level change of FACIT- fatigue, NFLymSI-18 and PROMIS fatigue measures (4a, 7a and 13a) in lymphoma.

Measuring group‑ and individual‑level change of FACIT- fatigue, NFLymSI-18 and PROMIS fatigue measures (4a, 7a and 13a) in lymphoma.

Journal: Journal of patient-reported outcomes

Published: October 05, 2025

Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy.

Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy.

Journal: JACC. CardioOncology

Published: August 18, 2025

Recurrent Myocarditis After COVID Vaccination in a Patient With FLNC Mutation Undergoing Treatment for Lymphoma.

Recurrent Myocarditis After COVID Vaccination in a Patient With FLNC Mutation Undergoing Treatment for Lymphoma.

Journal: JACC. Case reports

Published: August 14, 2025

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 30, 2025

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Journal: Cancers

Published: May 28, 2025

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

Journal: Blood advances

Published: May 09, 2025

Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index in Patients With Lymphoma.

Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index in Patients With Lymphoma.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 07, 2025

Showing 1-12 of 191

Last Updated: 09/26/2026